

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.52351750 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.57170603 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.31952626 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.29991772 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.29991772 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.15820509 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.15820509 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.89015053 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.83721744 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.68355280 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.57253231 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.46872878 |
| 13 | detection of other organism (GO:0098543) | 4.35860493 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 4.27880554 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.23531058 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.23531058 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.23531058 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.23531058 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.23531058 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 4.23531058 |
| 21 | detection of bacterium (GO:0016045) | 4.16305192 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 4.15402091 |
| 23 | negative thymic T cell selection (GO:0045060) | 4.14037820 |
| 24 | negative T cell selection (GO:0043383) | 4.12520518 |
| 25 | T cell migration (GO:0072678) | 4.09991088 |
| 26 | negative regulation of T cell mediated immunity (GO:0002710) | 4.06037349 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.02601461 |
| 28 | regulation of B cell differentiation (GO:0045577) | 4.00076869 |
| 29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.96740181 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.89102503 |
| 31 | leukocyte aggregation (GO:0070486) | 3.87325501 |
| 32 | activated T cell proliferation (GO:0050798) | 3.85115649 |
| 33 | response to interleukin-15 (GO:0070672) | 3.83454120 |
| 34 | interferon-gamma production (GO:0032609) | 3.71381965 |
| 35 | germinal center formation (GO:0002467) | 3.64615526 |
| 36 | detection of external biotic stimulus (GO:0098581) | 3.61831078 |
| 37 | thymic T cell selection (GO:0045061) | 3.60906240 |
| 38 | positive T cell selection (GO:0043368) | 3.57891932 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.53268498 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 3.53191443 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.52666766 |
| 42 | cellular response to interleukin-15 (GO:0071350) | 3.50984742 |
| 43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.50148445 |
| 44 | positive regulation of interferon-alpha production (GO:0032727) | 3.50070705 |
| 45 | detection of molecule of bacterial origin (GO:0032490) | 3.43876242 |
| 46 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.41814967 |
| 47 | microglial cell activation (GO:0001774) | 3.38165461 |
| 48 | positive regulation of mast cell activation (GO:0033005) | 3.35948858 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 3.35493363 |
| 50 | T cell selection (GO:0045058) | 3.35134270 |
| 51 | response to type I interferon (GO:0034340) | 3.34616537 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.34499212 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 3.34438537 |
| 54 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.31599285 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.30531067 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.26789342 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.26789342 |
| 58 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.26480370 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 3.25588463 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.23811259 |
| 61 | respiratory burst (GO:0045730) | 3.22310377 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.22193064 |
| 63 | tolerance induction (GO:0002507) | 3.21501814 |
| 64 | detection of biotic stimulus (GO:0009595) | 3.21326690 |
| 65 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.21122506 |
| 66 | regulation of mast cell activation (GO:0033003) | 3.19296683 |
| 67 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.19246115 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18463630 |
| 69 | response to host (GO:0075136) | 3.18463630 |
| 70 | response to host defenses (GO:0052200) | 3.18463630 |
| 71 | leukocyte cell-cell adhesion (GO:0007159) | 3.15654017 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 3.14779981 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14656031 |
| 74 | negative regulation of phagocytosis (GO:0050765) | 3.13593396 |
| 75 | macrophage activation (GO:0042116) | 3.12756792 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12038926 |
| 77 | positive regulation of antigen processing and presentation (GO:0002579) | 3.10689078 |
| 78 | mast cell activation (GO:0045576) | 3.07553380 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06861394 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 3.06625402 |
| 81 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05830965 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05119239 |
| 83 | regulation of T cell tolerance induction (GO:0002664) | 3.04799573 |
| 84 | defense response to protozoan (GO:0042832) | 3.02522586 |
| 85 | pinocytosis (GO:0006907) | 3.01633720 |
| 86 | response to peptidoglycan (GO:0032494) | 3.01082566 |
| 87 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.00636530 |
| 88 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.00636530 |
| 89 | cellular extravasation (GO:0045123) | 3.00387984 |
| 90 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.97604760 |
| 91 | leukocyte degranulation (GO:0043299) | 2.96751732 |
| 92 | neutrophil activation (GO:0042119) | 2.96688031 |
| 93 | B cell homeostasis (GO:0001782) | 2.95970050 |
| 94 | response to protozoan (GO:0001562) | 2.95937356 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95000370 |
| 96 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94350653 |
| 97 | positive regulation of isotype switching (GO:0045830) | 2.93577957 |
| 98 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.92545637 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 2.92545637 |
| 100 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92027128 |
| 101 | regulation of antigen processing and presentation (GO:0002577) | 2.91288905 |
| 102 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.90640017 |
| 103 | negative regulation of innate immune response (GO:0045824) | 2.90600070 |
| 104 | T cell receptor signaling pathway (GO:0050852) | 2.89833320 |
| 105 | negative regulation of granulocyte differentiation (GO:0030853) | 2.84471345 |
| 106 | mannose metabolic process (GO:0006013) | 2.83535725 |
| 107 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.81406522 |
| 108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80497445 |
| 109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.80025296 |
| 110 | negative regulation of interleukin-12 production (GO:0032695) | 2.79310979 |
| 111 | mature B cell differentiation (GO:0002335) | 2.78764219 |
| 112 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.77954624 |
| 113 | lymphocyte homeostasis (GO:0002260) | 2.77406816 |
| 114 | T cell homeostasis (GO:0043029) | 2.76185731 |
| 115 | T cell costimulation (GO:0031295) | 2.75264967 |
| 116 | myeloid dendritic cell activation (GO:0001773) | 2.74837775 |
| 117 | granulocyte activation (GO:0036230) | 2.74649975 |
| 118 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.73359207 |
| 119 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.72400510 |
| 120 | lymphocyte costimulation (GO:0031294) | 2.70980929 |
| 121 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.68758719 |
| 122 | regulation of response to interferon-gamma (GO:0060330) | 2.68303977 |
| 123 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.67736948 |
| 124 | cellular response to zinc ion (GO:0071294) | 2.67654867 |
| 125 | neutrophil mediated immunity (GO:0002446) | 2.67324768 |
| 126 | positive regulation of interleukin-2 production (GO:0032743) | 2.65957000 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.65640854 |
| 128 | heterotypic cell-cell adhesion (GO:0034113) | 2.65311125 |
| 129 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.64575472 |
| 130 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.63973560 |
| 131 | response to host immune response (GO:0052572) | 2.63973560 |
| 132 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.63659622 |
| 133 | B cell proliferation (GO:0042100) | 2.63549665 |
| 134 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.62888285 |
| 135 | B cell mediated immunity (GO:0019724) | 2.59265226 |
| 136 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.59041541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.09455535 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.73402855 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.46658476 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.12526621 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.72479974 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.54173167 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.49545426 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.29772073 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.24451011 |
| 10 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.00455959 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.97355100 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96713199 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.92288080 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.89104236 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85248581 |
| 16 | * MYC_22102868_ChIP-Seq_BL_Human | 2.80685837 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80079374 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.79587281 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.73355486 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.69305155 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.66669007 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.62415775 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.51234039 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.43057020 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42366176 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42059034 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40460405 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35444971 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.33418204 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.32685247 |
| 31 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18830918 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.17527688 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.17141312 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.13253641 |
| 35 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.11297106 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 2.06268146 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04106286 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.02845736 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92553734 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86748029 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.71807014 |
| 42 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70528295 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.66138744 |
| 44 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63068567 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62578446 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61970834 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60731957 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54634502 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54227274 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.52311634 |
| 51 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.51827016 |
| 52 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50115773 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49900819 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47743309 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45406083 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44494418 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41134972 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39575653 |
| 59 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38571647 |
| 60 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37983741 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37418987 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34879394 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32853620 |
| 64 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32377644 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31983764 |
| 66 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30384694 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.30136690 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25257623 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24167968 |
| 70 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.20127062 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17019981 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15047351 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14831055 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13666625 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12839890 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09661836 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07231035 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05294480 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02021926 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01974377 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01436397 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00336522 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00019586 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98033589 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97140460 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96771786 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95715110 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94720914 |
| 89 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93214635 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93019043 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92919756 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91332019 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90386712 |
| 94 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89442506 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88690168 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88220328 |
| 97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87902226 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87868301 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87727230 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86170781 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85622590 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84527241 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83649461 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82796607 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82569868 |
| 106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.81625332 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81496353 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75657773 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75622526 |
| 110 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74095171 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71633183 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71494944 |
| 113 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.71277415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.10186538 |
| 2 | MP0000685_abnormal_immune_system | 3.17907853 |
| 3 | MP0005671_abnormal_response_to | 3.05584138 |
| 4 | MP0001800_abnormal_humoral_immune | 2.96915680 |
| 5 | MP0000569_abnormal_digit_pigmentation | 2.93880444 |
| 6 | MP0001790_abnormal_immune_system | 2.85878017 |
| 7 | MP0005387_immune_system_phenotype | 2.85878017 |
| 8 | MP0003436_decreased_susceptibility_to | 2.79439809 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.73369522 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.71048492 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.59082534 |
| 12 | MP0002723_abnormal_immune_serum | 2.57996108 |
| 13 | MP0003303_peritoneal_inflammation | 2.54088306 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.53452057 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.53160242 |
| 16 | MP0002419_abnormal_innate_immunity | 2.52253733 |
| 17 | MP0001819_abnormal_immune_cell | 2.51551917 |
| 18 | MP0005025_abnormal_response_to | 2.48600707 |
| 19 | MP0009785_altered_susceptibility_to | 2.35503831 |
| 20 | MP0002398_abnormal_bone_marrow | 2.34524935 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.34019357 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.26742833 |
| 23 | MP0006054_spinal_hemorrhage | 2.19192169 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.14223590 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.14152884 |
| 26 | MP0000716_abnormal_immune_system | 2.10654203 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.08916804 |
| 28 | MP0006082_CNS_inflammation | 2.06844666 |
| 29 | MP0005058_abnormal_lysosome_morphology | 2.05119217 |
| 30 | MP0000689_abnormal_spleen_morphology | 2.04240898 |
| 31 | MP0002405_respiratory_system_inflammati | 2.04094010 |
| 32 | MP0002722_abnormal_immune_system | 1.95975739 |
| 33 | MP0004947_skin_inflammation | 1.93486319 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.88505374 |
| 35 | MP0004510_myositis | 1.88187922 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.83695195 |
| 37 | MP0001873_stomach_inflammation | 1.82684618 |
| 38 | MP0002006_tumorigenesis | 1.81508848 |
| 39 | MP0002429_abnormal_blood_cell | 1.76858462 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.76270036 |
| 41 | MP0009278_abnormal_bone_marrow | 1.75990981 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.72858354 |
| 43 | MP0003724_increased_susceptibility_to | 1.68880359 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.68494056 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.67850476 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.66270996 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.66270996 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.62770542 |
| 49 | MP0005451_abnormal_body_composition | 1.58936192 |
| 50 | MP0008260_abnormal_autophagy | 1.55737054 |
| 51 | MP0001853_heart_inflammation | 1.46906252 |
| 52 | MP0003448_altered_tumor_morphology | 1.43079937 |
| 53 | MP0000858_altered_metastatic_potential | 1.37280820 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.32817080 |
| 55 | MP0001851_eye_inflammation | 1.32760426 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.32566934 |
| 57 | MP0002933_joint_inflammation | 1.30893987 |
| 58 | MP0008469_abnormal_protein_level | 1.30117822 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.26188973 |
| 60 | MP0004883_abnormal_blood_vessel | 1.25234296 |
| 61 | MP0003866_abnormal_defecation | 1.24334074 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.21755999 |
| 63 | MP0003690_abnormal_glial_cell | 1.21474419 |
| 64 | MP0010307_abnormal_tumor_latency | 1.21204067 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.20417383 |
| 66 | MP0000490_abnormal_crypts_of | 1.19650127 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.16942764 |
| 68 | MP0001958_emphysema | 1.16863880 |
| 69 | MP0002132_abnormal_respiratory_system | 1.10119359 |
| 70 | MP0005310_abnormal_salivary_gland | 1.05297638 |
| 71 | MP0000343_altered_response_to | 1.02252066 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.01278553 |
| 73 | MP0000604_amyloidosis | 1.00880571 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.98847008 |
| 75 | MP0005164_abnormal_response_to | 0.93745392 |
| 76 | MP0005075_abnormal_melanosome_morpholog | 0.92890238 |
| 77 | MP0000371_diluted_coat_color | 0.92031272 |
| 78 | MP0008004_abnormal_stomach_pH | 0.90113775 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.88849768 |
| 80 | MP0005023_abnormal_wound_healing | 0.85965394 |
| 81 | MP0002019_abnormal_tumor_incidence | 0.83552052 |
| 82 | MP0003279_aneurysm | 0.82002210 |
| 83 | MP0010352_gastrointestinal_tract_polyps | 0.80726551 |
| 84 | MP0002095_abnormal_skin_pigmentation | 0.79737963 |
| 85 | MP0001915_intracranial_hemorrhage | 0.79300283 |
| 86 | MP0003091_abnormal_cell_migration | 0.77495398 |
| 87 | MP0000249_abnormal_blood_vessel | 0.77344342 |
| 88 | MP0003828_pulmonary_edema | 0.76662017 |
| 89 | MP0001663_abnormal_digestive_system | 0.75468979 |
| 90 | MP0003045_fibrosis | 0.74712075 |
| 91 | MP0009764_decreased_sensitivity_to | 0.74639847 |
| 92 | MP0008057_abnormal_DNA_replication | 0.73308347 |
| 93 | MP0009763_increased_sensitivity_to | 0.71006074 |
| 94 | MP0008438_abnormal_cutaneous_collagen | 0.70675481 |
| 95 | MP0001243_abnormal_dermal_layer | 0.70259456 |
| 96 | MP0004130_abnormal_muscle_cell | 0.69832148 |
| 97 | MP0003795_abnormal_bone_structure | 0.68219501 |
| 98 | MP0005166_decreased_susceptibility_to | 0.65991925 |
| 99 | MP0005390_skeleton_phenotype | 0.64596532 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.64248888 |
| 101 | MP0003077_abnormal_cell_cycle | 0.64139248 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.62785298 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.62685395 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.58507178 |
| 105 | MP0002928_abnormal_bile_duct | 0.58197278 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.57996488 |
| 107 | MP0002009_preneoplasia | 0.57771232 |
| 108 | MP0009840_abnormal_foam_cell | 0.57554503 |
| 109 | MP0009115_abnormal_fat_cell | 0.54502837 |
| 110 | MP0002060_abnormal_skin_morphology | 0.53627057 |
| 111 | MP0003075_altered_response_to | 0.52359912 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.52160025 |
| 113 | MP0004381_abnormal_hair_follicle | 0.51799521 |
| 114 | MP0005621_abnormal_cell_physiology | 0.51384871 |
| 115 | MP0008874_decreased_physiological_sensi | 0.50411147 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.49580100 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.47541442 |
| 118 | MP0000920_abnormal_myelination | 0.47382978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.95288775 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.65179279 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.70616737 |
| 4 | Recurrent viral infections (HP:0004429) | 4.02433295 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.02045975 |
| 6 | Absent frontal sinuses (HP:0002688) | 3.89929378 |
| 7 | Recurrent skin infections (HP:0001581) | 3.83970538 |
| 8 | Spinal cord lesions (HP:0100561) | 3.77030523 |
| 9 | Syringomyelia (HP:0003396) | 3.77030523 |
| 10 | Myositis (HP:0100614) | 3.69249224 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.65028538 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.58532778 |
| 13 | Prostate neoplasm (HP:0100787) | 3.46659472 |
| 14 | Spondylolisthesis (HP:0003302) | 3.43164776 |
| 15 | IgM deficiency (HP:0002850) | 3.39273683 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38435369 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38435369 |
| 18 | T lymphocytopenia (HP:0005403) | 3.35607440 |
| 19 | Encephalitis (HP:0002383) | 3.33551270 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32708855 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30930760 |
| 22 | Agnosia (HP:0010524) | 3.29386695 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.23471235 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.21229827 |
| 25 | Chronic otitis media (HP:0000389) | 3.19028124 |
| 26 | Metaphyseal dysplasia (HP:0100255) | 3.15270221 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.14497637 |
| 28 | Pustule (HP:0200039) | 3.12915786 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.10873866 |
| 30 | Cellulitis (HP:0100658) | 3.08139739 |
| 31 | Recurrent bronchitis (HP:0002837) | 3.00834242 |
| 32 | Disinhibition (HP:0000734) | 2.94624325 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.93087436 |
| 34 | Obstructive lung disease (HP:0006536) | 2.93087436 |
| 35 | Meningitis (HP:0001287) | 2.91328626 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.89205559 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.86680394 |
| 38 | Abnormality of the fingertips (HP:0001211) | 2.86017423 |
| 39 | Keratoconjunctivitis (HP:0001096) | 2.83352855 |
| 40 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.83251717 |
| 41 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.81530405 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.79349028 |
| 43 | Gingivitis (HP:0000230) | 2.79117452 |
| 44 | Stomatitis (HP:0010280) | 2.78862828 |
| 45 | Urticaria (HP:0001025) | 2.76566530 |
| 46 | Abnormality of T cells (HP:0002843) | 2.75524133 |
| 47 | Vasculitis (HP:0002633) | 2.75267438 |
| 48 | Orchitis (HP:0100796) | 2.74689680 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.73323474 |
| 50 | Optic neuritis (HP:0100653) | 2.72093002 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.72093002 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.71493354 |
| 53 | Periodontitis (HP:0000704) | 2.70256583 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.69626888 |
| 55 | Colitis (HP:0002583) | 2.67802233 |
| 56 | Thrombocytosis (HP:0001894) | 2.66399617 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.64164741 |
| 58 | Agammaglobulinemia (HP:0004432) | 2.62812388 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.59151900 |
| 60 | Nasal polyposis (HP:0100582) | 2.48028802 |
| 61 | Epistaxis (HP:0000421) | 2.47035163 |
| 62 | Leukocytosis (HP:0001974) | 2.44325903 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.39684060 |
| 64 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.35984795 |
| 65 | Arterial thrombosis (HP:0004420) | 2.35516251 |
| 66 | Abnormality of the frontal sinuses (HP:0002687) | 2.35373805 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.35053162 |
| 68 | Abnormal platelet function (HP:0011869) | 2.33998692 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.33998692 |
| 70 | Increased IgM level (HP:0003496) | 2.33682362 |
| 71 | Osteomyelitis (HP:0002754) | 2.33381203 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31046871 |
| 73 | Petechiae (HP:0000967) | 2.29734230 |
| 74 | Loss of speech (HP:0002371) | 2.28803584 |
| 75 | Abnormal platelet volume (HP:0011876) | 2.27431105 |
| 76 | Viral hepatitis (HP:0006562) | 2.26405052 |
| 77 | Pulmonary embolism (HP:0002204) | 2.25521227 |
| 78 | Lymphopenia (HP:0001888) | 2.25169240 |
| 79 | Myocardial infarction (HP:0001658) | 2.25030257 |
| 80 | Gingival bleeding (HP:0000225) | 2.24410936 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.23985301 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.20041560 |
| 83 | Hemoptysis (HP:0002105) | 2.19937862 |
| 84 | Increased IgE level (HP:0003212) | 2.19738000 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.18444147 |
| 86 | Anorexia (HP:0002039) | 2.17037131 |
| 87 | Amyloidosis (HP:0011034) | 2.16943035 |
| 88 | Autoimmune hemolytic anemia (HP:0001890) | 2.16914873 |
| 89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16265401 |
| 90 | Eosinophilia (HP:0001880) | 2.16138895 |
| 91 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.15579995 |
| 92 | Increased serum ferritin (HP:0003281) | 2.15435227 |
| 93 | Episodic fever (HP:0001954) | 2.14735679 |
| 94 | Hematochezia (HP:0002573) | 2.11591397 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.10589256 |
| 96 | Emphysema (HP:0002097) | 2.09860803 |
| 97 | Osteolytic defects of the hand bones (HP:0009699) | 2.05502491 |
| 98 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05502491 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.05255272 |
| 100 | Thyroiditis (HP:0100646) | 2.02670354 |
| 101 | Verrucae (HP:0200043) | 2.01578554 |
| 102 | Papilloma (HP:0012740) | 2.01578554 |
| 103 | IgG deficiency (HP:0004315) | 2.00549612 |
| 104 | Chest pain (HP:0100749) | 1.99305110 |
| 105 | Skin ulcer (HP:0200042) | 1.98842771 |
| 106 | Keratoconjunctivitis sicca (HP:0001097) | 1.98733322 |
| 107 | Abnormality of the pleura (HP:0002103) | 1.97808093 |
| 108 | Sepsis (HP:0100806) | 1.97516924 |
| 109 | Amaurosis fugax (HP:0100576) | 1.96119647 |
| 110 | Hypochromic anemia (HP:0001931) | 1.95677348 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.95127291 |
| 112 | Granulocytopenia (HP:0001913) | 1.95023071 |
| 113 | Peritonitis (HP:0002586) | 1.94272102 |
| 114 | Gangrene (HP:0100758) | 1.94179001 |
| 115 | Abnormality of eosinophils (HP:0001879) | 1.93005905 |
| 116 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.92364204 |
| 117 | Glomerulopathy (HP:0100820) | 1.91987164 |
| 118 | Dysostosis multiplex (HP:0000943) | 1.91738601 |
| 119 | Slow saccadic eye movements (HP:0000514) | 1.91564688 |
| 120 | Restrictive lung disease (HP:0002091) | 1.90145734 |
| 121 | Hepatosplenomegaly (HP:0001433) | 1.89666575 |
| 122 | Abnormality of the endocardium (HP:0004306) | 1.89628646 |
| 123 | Purpura (HP:0000979) | 1.89572571 |
| 124 | Abnormality of B cell number (HP:0010975) | 1.89338081 |
| 125 | B lymphocytopenia (HP:0010976) | 1.89338081 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89328438 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89328438 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89328438 |
| 129 | Fatigue (HP:0012378) | 1.89053554 |
| 130 | Cheilitis (HP:0100825) | 1.87465994 |
| 131 | Polyneuropathy (HP:0001271) | 1.87265857 |
| 132 | Joint swelling (HP:0001386) | 1.86567378 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85253084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.84802788 |
| 2 | PRPF4B | 3.42591004 |
| 3 | JAK3 | 3.32206081 |
| 4 | TYK2 | 2.90995465 |
| 5 | TXK | 2.67949859 |
| 6 | KIT | 2.57450917 |
| 7 | MAP3K14 | 2.40427417 |
| 8 | ZAP70 | 2.35493835 |
| 9 | IRAK4 | 2.29491353 |
| 10 | TBK1 | 2.12701592 |
| 11 | BLK | 2.12665610 |
| 12 | IRAK3 | 2.12476241 |
| 13 | STK10 | 2.11614756 |
| 14 | IKBKE | 2.04831332 |
| 15 | JAK1 | 1.95885198 |
| 16 | MAP3K13 | 1.89111535 |
| 17 | CSF1R | 1.86496610 |
| 18 | GRK6 | 1.86368456 |
| 19 | TAOK3 | 1.81786963 |
| 20 | TGFBR2 | 1.80819688 |
| 21 | BTK | 1.79363526 |
| 22 | ITK | 1.79331838 |
| 23 | RIPK4 | 1.68420760 |
| 24 | SIK2 | 1.67380875 |
| 25 | SYK | 1.66574227 |
| 26 | MAP3K10 | 1.65069557 |
| 27 | PKN2 | 1.60884070 |
| 28 | EEF2K | 1.56504188 |
| 29 | LCK | 1.56075967 |
| 30 | IKBKB | 1.55330503 |
| 31 | HCK | 1.54353166 |
| 32 | TEC | 1.52212189 |
| 33 | TTN | 1.50353234 |
| 34 | FES | 1.39289600 |
| 35 | CSK | 1.35829065 |
| 36 | TRIB3 | 1.33672317 |
| 37 | LRRK2 | 1.30129055 |
| 38 | CDK12 | 1.27932636 |
| 39 | FGFR4 | 1.26572096 |
| 40 | MAP2K3 | 1.24184040 |
| 41 | FLT3 | 1.24145473 |
| 42 | CLK1 | 1.23908194 |
| 43 | MARK3 | 1.23087600 |
| 44 | MAP3K3 | 1.22005229 |
| 45 | PIM1 | 1.18829513 |
| 46 | ERN1 | 1.16262713 |
| 47 | FGFR3 | 1.09318243 |
| 48 | BMPR2 | 1.06256958 |
| 49 | CDC42BPA | 1.05070838 |
| 50 | RPS6KA4 | 1.04543997 |
| 51 | JAK2 | 1.04297116 |
| 52 | NME2 | 1.04098818 |
| 53 | TAOK1 | 1.02107271 |
| 54 | NEK9 | 1.01166817 |
| 55 | LYN | 1.00618837 |
| 56 | TRPM7 | 0.99907990 |
| 57 | MAP3K1 | 0.99668047 |
| 58 | MARK2 | 0.95087777 |
| 59 | BRD4 | 0.95029791 |
| 60 | CAMK1D | 0.94363459 |
| 61 | KSR2 | 0.92620926 |
| 62 | GRK7 | 0.92149892 |
| 63 | MAP3K11 | 0.90771442 |
| 64 | CHUK | 0.89013345 |
| 65 | CAMKK2 | 0.83290573 |
| 66 | EPHB1 | 0.81925152 |
| 67 | CDK6 | 0.81643683 |
| 68 | YES1 | 0.80512262 |
| 69 | MAP3K8 | 0.77526557 |
| 70 | STK4 | 0.76323555 |
| 71 | RPS6KA6 | 0.76219571 |
| 72 | PIK3CG | 0.74433852 |
| 73 | PDK1 | 0.72349772 |
| 74 | CAMK1G | 0.71731543 |
| 75 | PTK6 | 0.68370900 |
| 76 | RPS6KC1 | 0.67436796 |
| 77 | RPS6KL1 | 0.67436796 |
| 78 | TAOK2 | 0.66328441 |
| 79 | NEK2 | 0.66281314 |
| 80 | PRKCQ | 0.64973031 |
| 81 | IRAK1 | 0.64929872 |
| 82 | SMG1 | 0.64915763 |
| 83 | TNK2 | 0.63408452 |
| 84 | TESK2 | 0.61140332 |
| 85 | CAMKK1 | 0.60136119 |
| 86 | MOS | 0.59583028 |
| 87 | PRKCH | 0.57991616 |
| 88 | CDK4 | 0.57816496 |
| 89 | CDK9 | 0.56532322 |
| 90 | RPS6KA2 | 0.56379203 |
| 91 | PDGFRB | 0.56077664 |
| 92 | MAP3K6 | 0.53515869 |
| 93 | IRAK2 | 0.52734976 |
| 94 | NLK | 0.51557359 |
| 95 | MAPK4 | 0.46991369 |
| 96 | RET | 0.45770679 |
| 97 | ABL1 | 0.45437260 |
| 98 | PAK4 | 0.45119589 |
| 99 | EGFR | 0.44963264 |
| 100 | SCYL2 | 0.44232137 |
| 101 | MATK | 0.43962333 |
| 102 | SIK3 | 0.43575952 |
| 103 | HIPK2 | 0.42535375 |
| 104 | MAP3K7 | 0.42116867 |
| 105 | PDPK1 | 0.39433739 |
| 106 | MAP3K2 | 0.39404110 |
| 107 | MAPKAPK2 | 0.39276235 |
| 108 | MELK | 0.38721349 |
| 109 | ATR | 0.35552864 |
| 110 | RAF1 | 0.35060390 |
| 111 | MAPK11 | 0.34993200 |
| 112 | MAPK3 | 0.34767893 |
| 113 | SGK3 | 0.32662515 |
| 114 | PRKCD | 0.32578830 |
| 115 | MAP3K5 | 0.32319860 |
| 116 | RIPK1 | 0.30773618 |
| 117 | FYN | 0.29258901 |
| 118 | STK24 | 0.28832945 |
| 119 | PIM2 | 0.28754047 |
| 120 | SIK1 | 0.28281953 |
| 121 | KDR | 0.26630109 |
| 122 | ALK | 0.25810785 |
| 123 | PRKD2 | 0.25508804 |
| 124 | MAPK7 | 0.24261540 |
| 125 | FGR | 0.24256229 |
| 126 | MAPK12 | 0.23596753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.10315689 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.77995075 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.67612070 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.55275652 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.44372691 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.38944972 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.24569845 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12962329 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.05293108 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04882270 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04232868 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.03443558 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87493344 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86286106 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82292539 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71327096 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70047518 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.69360691 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.67170063 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66363862 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63687653 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62485006 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61698298 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55489368 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51311119 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.50921754 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49929720 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48450301 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.44639969 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44525594 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.41004841 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39863354 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38002587 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37666667 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.37365240 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36193814 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.36033426 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.35658376 |
| 39 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34313594 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.34297170 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33647686 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27730354 |
| 43 | * Platelet activation_Homo sapiens_hsa04611 | 1.27469589 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26548125 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.18314168 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12435946 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12345149 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.09914600 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07531019 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.06825648 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00444538 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95237523 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95013442 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92879499 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90865938 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90514991 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.86695235 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86387754 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82782512 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82553864 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82160464 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.81049604 |
| 63 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.80823613 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77854067 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71555674 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 0.70469571 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67935677 |
| 68 | Base excision repair_Homo sapiens_hsa03410 | 0.65742505 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65537565 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65279295 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65273029 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65194640 |
| 73 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65068931 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63305007 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62745973 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61773731 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59576926 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59077475 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.56844039 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55933010 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55075800 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.54006037 |
| 83 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53453809 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52357480 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51602985 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50963684 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50871548 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.50194232 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49765740 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.47149681 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.46615169 |
| 92 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46444040 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44906087 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44667111 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44400980 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42625216 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.42060296 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41493370 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41237116 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41011988 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40863930 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38604717 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38391727 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37579701 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35748957 |
| 106 | Mismatch repair_Homo sapiens_hsa03430 | 0.35682185 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.34411016 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.33167757 |
| 109 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32737000 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32368455 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31664143 |
| 112 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30992145 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29796455 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29709875 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28630121 |

